105 related articles for article (PubMed ID: 1312890)
1. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC).
Yano H; Maruiwa M; Iemura A; Mizoguchi A; Kojiro M
Cancer; 1992 Apr; 69(7):1664-73. PubMed ID: 1312890
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a subcutaneous model of the human extrahepatic bile duct carcinoma in nude mice via transplantation of histologically intact tumor tissue.
Tang WH; Yuan ST; Wang BS; Lu LJ; Ding J; Yuan ZR
J Exp Clin Cancer Res; 2004 Dec; 23(4):661-7. PubMed ID: 15743037
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (ICBD-1).
Takiyama I; Terashima M; Ikeda K; Kawamura H; Kashiwaba M; Tamura G; Suto T; Nakashima F; Sasaki R; Saito K
Oncol Rep; 1998; 5(2):463-7. PubMed ID: 9468580
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and characterization of human cholaginocarcinoma, MEC, producing carbohydrate antigen 19-9].
Yoshida K; Tomizawa H; Ota T; Nagashima T; Kikuchi H; Watanabe H; Hashizaki K; Yonaha A
Hum Cell; 1990 Dec; 3(4):346-51. PubMed ID: 1965684
[TBL] [Abstract][Full Text] [Related]
5. A cholangiocellular carcinoma nude mouse strain showing histologic alteration from adenocarcinoma to squamous cell carcinoma.
Iemura A; Yano H; Mizoguchi A; Kojiro M
Cancer; 1992 Jul; 70(2):415-22. PubMed ID: 1319814
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a cell line from a human cholangiocellular carcinoma.
Kusaka Y; Tokiwa T; Sato J
Res Exp Med (Berl); 1988; 188(5):367-75. PubMed ID: 2852388
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.
Saijyo S; Kudo T; Suzuki M; Katayose Y; Shinoda M; Muto T; Fukuhara K; Suzuki T; Matsuno S
Tohoku J Exp Med; 1995 Sep; 177(1):61-71. PubMed ID: 8693487
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model.
Yamada N; Chung YS; Arimoto Y; Sawada T; Seki S; Sowa M
Br J Cancer; 1995 Mar; 71(3):543-8. PubMed ID: 7880737
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and characterization of a human cholangiocellular carcinoma cell line].
Kusaka Y; Muraoka A; Tokiwa T; Sato J
Hum Cell; 1988 Mar; 1(1):92-4. PubMed ID: 2856443
[TBL] [Abstract][Full Text] [Related]
10. A new human cholangiocellular carcinoma cell line (KMC-1).
Iemura A; Maruiwa M; Yano H; Kojiro M
J Hepatol; 1992 Jul; 15(3):288-98. PubMed ID: 1332997
[TBL] [Abstract][Full Text] [Related]
11. Cancer of the extrahepatic bile duct: a clinicopathologic study of immunohistochemistry for CEA, CA19-9, and p21.
Yamaguchi K; Enjoji M; Nakayama F
World J Surg; 1988 Feb; 12(1):11-7. PubMed ID: 2830725
[No Abstract] [Full Text] [Related]
12. A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.
Yano H; Iemura A; Haramaki M; Momosaki S; Ogasawara S; Higaki K; Kojiro M
J Hepatol; 1996 Apr; 24(4):413-22. PubMed ID: 8738727
[TBL] [Abstract][Full Text] [Related]
13. A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium.
Miyagiwa M; Ichida T; Tokiwa T; Sato J; Sasaki H
In Vitro Cell Dev Biol; 1989 Jun; 25(6):503-10. PubMed ID: 2544546
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of a human combined hepatocholangiocarcinoma cell line and its heterologous transplantation in nude mice.
Murakami T; Yano H; Maruiwa M; Sugihara S; Kojiro M
Hepatology; 1987; 7(3):551-6. PubMed ID: 3032760
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of human hilar bile duct carcinoma cell line and cell strain.
Jiao W; Yakushiji H; Kitajima Y; Ogawa A; Miyazaki K
J Hepatobiliary Pancreat Surg; 2000; 7(4):417-25. PubMed ID: 11180864
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a cholangiocarcinoma cell line from a Thai patient with intrahepatic bile duct cancer.
Sirisinha S; Tengchaisri T; Boonpucknavig S; Prempracha N; Ratanarapee S; Pausawasdi A
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):153-7. PubMed ID: 1666951
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal breakpoints in cholangiocarcinoma cell lines.
Storto PD; Saidman SL; Demetris AJ; Letessier E; Whiteside TL; Gollin SM
Genes Chromosomes Cancer; 1990 Nov; 2(4):300-10. PubMed ID: 2176543
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a human hepatic adenosquamous carcinoma cell line (KMC-2) and its response to cytokines.
Momosaki S; Yano H; Kojiro M
Pathol Int; 1995 Feb; 45(2):137-46. PubMed ID: 7742926
[TBL] [Abstract][Full Text] [Related]
19. High level of CA19-9, CA50, and CEA-producible human cholangiocarcinoma cell line changes in the secretion ratios in vitro or in vivo.
Watanabe M; Chigusa M; Takahashi H; Nakamura J; Tanaka H; Ohno T
In Vitro Cell Dev Biol Anim; 2000 Feb; 36(2):104-9. PubMed ID: 10718366
[TBL] [Abstract][Full Text] [Related]
20. Expression of new phenotypic markers in cholangiocarcinoma and putative precursor lesions.
Roncalli M; Patriarca C; Gambacorta M; Viale G; Coggi G
J Surg Oncol Suppl; 1993; 3():173-4. PubMed ID: 7684914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
